SONY PICTURES' SPIDER-MAN: BRAND NEW DAY BECOMES CJ 4DPLEX'S HIGHEST-GROSSING FILM OF ALL TIME ACROSS SCREENX AND 4DX

Spider-Man: Brand New Day became the top CJ 4DPLEX SCREENX/4DX film, generating $104M+ in combined global box office and surpassing Avatar: The Way of Water’s $103M record in just 33 days. The movie drew 6.7M+ admissions across 1,200 screens with a record 40% average occupancy and set opening records in 36 SCREENX countries and 22 4DX countries. The debut of CJ 4DPLEX’s “Shot for SCREENX” on-set-to-theater collaboration is positioned as proof of demand for premium immersive formats, now expanding in major markets worldwide.

Analysis

The market implication is less about one title and more about proof that premium-format capacity is still underpenetrated relative to consumer willingness to pay. That favors exhibitors with the ability to monetize premium real estate and content owners that can pre-sell tentpoles into differentiated formats; it is structurally worse for chains stuck with undifferentiated screens because they absorb fixed costs without the pricing uplift. The second-order winner may be premium-format licensors and integrators, since successful upstream collaboration increases switching costs and deepens studio dependence on their pipelines.

Near term, this is a read-through to the premium-experience complex rather than a broad theater beta trade. The key catalyst over the next 1-3 months is whether the next few franchise releases sustain similar occupancy and premium-ticket conversion; if they do not, this will be treated as a one-off crowding event, not a secular step-up. Over 6-18 months, the meaningful question is whether studios allocate more production time and marketing dollars to format-specific releases, which would widen the moat around premium operators and pressure standard-format exhibitors.

Contrarian view: the consensus may be extrapolating a supply-constrained hit into a durable demand regime. Premium occupancy at this level can still be a function of scarce screens and a single franchise, not a proof that the category can scale across the slate. If the next tentpoles fail to match premium occupancy or if admission growth stalls outside the biggest IP, the valuation premium in premium-format proxies should compress quickly.

Key Decisions for Investors

• Watchlist, not conviction trade: use IMAX as the cleanest public proxy for premium theatrical demand; consider adding on pullbacks only if the next 2-3 franchise releases sustain premium occupancy and box-office mix.
• Relative-value idea: long CNK / short AMC for 1-3 months, targeting the operators most able to monetize premium screens versus the most balance-sheet-constrained chain. Falsify if AMC shows outsized premium-format mix growth or CNK guides down on premium yields.
• If you want a lower-beta expression, buy a small basket of premium-experience leaders on weakness after the next box-office print rather than chasing the headline; the setup is better as a sequential confirmation trade than a gap-and-go.
• Alert item: if studio commentary in the next earnings cycle mentions expanding format-specific production or higher marketing allocations to premium screens, that would be the first evidence this is becoming a 6-18 month structural story.
• Avoid a broad long-theaters basket here; the signal is concentrated in premium monetization, not in commodity attendance. Use standard-screen weakness as a hedge if taking any premium-experience long.